Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

957
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
957
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

625
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
625
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

490
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
490
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

702
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
702

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.

Annals of medicine·2026
Same author

Advances and updates in antibiotic combination therapy.

Expert review of anti-infective therapy·2025
Same author

Antiviral Combination Treatment for COVID-19 in Immunocompromised Patients: Towards Defining Its Place in Therapy.

Infectious diseases and therapy·2025
Same author

Three Cases of Human Babesiosis, Italy, 2017-2020.

Emerging infectious diseases·2025
Same author

Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIV.

AIDS (London, England)·2024
Same author

COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospital.

Journal of chemotherapy (Florence, Italy)·2024

Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
06:46

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

Published on: December 22, 2023

1.3K

[Kidney toxicity's "HAART" therapy].

Alfonsina Marino, Francesco Ardu, Chiara Dentone

    Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
    |October 20, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Human immunodeficiency virus (HIV) treatment can harm kidneys, but highly active antiretroviral therapy (HAART) often improves kidney function. Physicians must monitor renal function during HIV therapy, especially in patients with risk factors for kidney damage.

    More Related Videos

    Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
    07:13

    Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

    Published on: April 12, 2021

    5.4K
    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    1.9K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
    06:46

    Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

    Published on: December 22, 2023

    1.3K
    Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
    07:13

    Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

    Published on: April 12, 2021

    5.4K
    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    1.9K

    Area of Science:

    • Nephrology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Human immunodeficiency virus (HIV) infection and its treatment can negatively impact kidney health.
    • Antiretroviral therapies are crucial for managing HIV but may present risks to renal function.

    Purpose of the Study:

    • To review the effects of antiretroviral therapy on kidney function in HIV-infected patients.
    • To highlight potential renal complications associated with highly active antiretroviral therapy (HAART).

    Main Methods:

    • Literature review of studies examining renal function in HIV patients undergoing antiretroviral therapy.
    • Analysis of known nephrotoxic effects of various antiretroviral drug classes.

    Main Results:

    • HAART generally improves renal function by suppressing viral replication.
    • Specific antiretroviral drugs can cause various kidney issues, including acute tubular necrosis, interstitial nephritis, and crystal nephropathy.
    • Metabolic disturbances like hyperlipidemia and altered calcium/phosphorus levels are observed.

    Conclusions:

    • Close monitoring of renal function is essential before and during HAART.
    • Patients with pre-existing risk factors (hypertension, hepatitis B/C) require particular attention for potential drug-induced kidney damage.